★ Sign in to follow
MJ

Martin Jönsson

Executive
Chairman & CEO
SE·Finansinspektionen
AlzeCure Pharma ABNordnet AB (publ)
Insider activity · 24 months3 buys0 salesCumulative net flow
Total declarations
17
Companies
2
▲ Purchases (6 ops.)
€153k
▼ Sales (0 ops.)
—

Latest filing published 04 Jul 2026 for AlzeCure Pharma AB, €22k.

Filing timeline

BuySale
Martin Jönsson

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Martin Jönsson: trading record in brief

This profile gathers the share dealings of Martin Jönsson across 2 companies, led by AlzeCure Pharma AB and Nordnet AB (publ). Between 20 May 2020 and 2 July 2026, the trades on record add up to 17 filings.

No open-market sale appears; the market trades are 6 purchases worth €153k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 2 purchases and no sales.

A typical purchase (the median) is worth €11k. Measured against the company's value, the median purchase equals 0.0001% of market capitalisation, across 3 purchases where it is known. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

On 4 July 2026 came the latest disclosure, a transaction for €22k in AlzeCure Pharma AB. The last insider purchase was made public on 6 March 2026, 247 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Martin Jönsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    242,237 SEK0FI-SE
    184,914 shares@ SEK 1.3193.2% of flowBTA (betald tecknad aktie)ISIN SE0028850099FI:csv-cd6e11af1a52c2985dd2
  • ▲
    Martin Jönsson
    StyrelseledamotExecutivesNordnet AB (publ)
    28,000 SEK9FI-SE
    5,000 shares@ SEK 5.600.0000% mcap19.8% of flowAktieISIN SE0009580517FI:A003W808-1
    Canonical exit: 4 Jun 2026 (T+90)
  • ▲
    Martin Jönsson
    StyrelseledamotExecutivesNordnet AB (publ)
    112,860 SEK15FI-SE
    19,800 shares@ SEK 5.700.0001% mcap80.2% of flowAktieISIN SE0009580517FI:A003W633-1
    Canonical exit: 31 May 2026 (T+90)
  • ▲
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    17,667 SEK35FI-SE
    8,067 shares@ SEK 2.190.0020% mcap6.8% of flowAktieISIN SE0025399124FI:A003R766-1
    Canonical exit: 23 Nov 2025 (T+90)
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    52,270 SEK0FI-SE
    23,759 shares@ SEK 2.20BTA (betald tecknad aktie)ISIN SE0025399132FI:csv-c4566f7900470e9a7066
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    392,808 SEK0FI-SE
    178,549 shares@ SEK 2.20BTA (betald tecknad aktie)ISIN SE0025399132FI:csv-5c22a35e7ae07716bc7d
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    170,000 SEK0FI-SE
    100,000 shares@ SEK 1.704.5% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:csv-73faa861846e832977bc
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    141,610 SEK0FI-SE
    83,300 shares@ SEK 1.703.7% of flowBTA (betald tecknad aktie)ISIN SE0022060802FI:csv-e373cc8900cbee59e7d5
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    206,436 SEK0FI-SE
    121,433 shares@ SEK 1.705.4% of flowBTA (betald tecknad aktie)ISIN SE0022060802FI:csv-6b235e2ce644af687cf4
  • ▲
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    420,000 SEK0FI-SE
    500,000 shares@ SEK 0.8411.0% of flowTeckningsoptionISIN SE0010133785FI:csv-4384968aa441fd071189
    Canonical exit: 28 Aug 2023 (T+90)
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    816,731 SEK0FI-SE
    217,795 shares@ SEK 3.7522.5% of flowBTA (betald tecknad aktie)ISIN SE0019174087FI:csv-3cd19372dfe2be9380f6
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    94,016 SEK0FI-SE
    25,071 shares@ SEK 3.752.6% of flowBTA (betald tecknad aktie)ISIN SE0019174087FI:csv-d089dac26d2153a9220e
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    89,250 SEK0FI-SE
    23,800 shares@ SEK 3.752.5% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:csv-e5225d0202656fe23c90
  • ●
    Martin Jönsson
    Verkställande direktör (VD)ExecutivesAlzeCure Pharma AB
    163,200 SEK0FI-SE
    40,800 shares@ SEK 4.004.8% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:csv-9f6db6bdb7eed333f8ee
  • ▲
    Martin Jönsson
    VDExecutivesAlzeCure Pharma AB
    954,720 SEK29FI-SE
    102,000 shares@ SEK 9.3672.8% of flowAktieISIN SE0010133785FI:csv-67f536c6ecb455bf4b48
    Canonical exit: 14 Jan 2021 (T+90)
  • ▲
    Martin Jönsson
    VDExecutivesAlzeCure Pharma AB
    114,000 SEK0FI-SE
    300,000 shares@ SEK 0.3831.7% of flowOptionISIN SE0010133785FI:csv-c939c575c177f5e5192e
    Canonical exit: 18 Aug 2020 (T+90)

16 of 16 declarations

Related entities

No related entities found.